INDP
Price
$3.00
Change
-$0.16 (-5.06%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
421.05M
20 days until earnings call
Intraday BUY SELL Signals
NBP
Price
$1.33
Change
-$0.04 (-2.92%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
158.44M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INDP vs NBP

INDP vs NBP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
INDP vs. NBP commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDP is a Hold and NBP is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for INDP with price predictions
Oct 21, 2026

INDP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for INDP turned positive on October 21, 2026. Looking at past instances where INDP's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on INDP as a result. In 79 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

Following a +15.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where INDP advanced for three days, in 167 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 55 of 77 cases where INDP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for INDP moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 15 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

INDP broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. INDP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (37.023) is normal, around the industry mean (2.988). P/E Ratio (-0.888) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INDP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for NBP with price predictions
Oct 21, 2026

NBP's RSI Oscillator ascends from oversold territory

The RSI Oscillator for NBP moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 34 of the 41 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 68 cases where NBP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NBP as a result. In 63 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

The Moving Average Convergence Divergence (MACD) for NBP just turned positive on October 08, 2026. Looking at past instances where NBP's MACD turned positive, the stock continued to rise in 28 of 39 cases over the following month. The odds of a continued upward trend are 72%.

Following a +13.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where NBP advanced for three days, in 165 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

NBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NBP entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.788) is normal, around the industry mean (2.988). P/E Ratio (-1.986) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. NBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
INDP vs NBP: Fundamental Ratings
INDP
NBP
OUTLOOK RATING
1..100
812
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6182
P/E GROWTH RATING
1..100
7519
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBP's Valuation (34) in the null industry is somewhat better than the same rating for INDP (91). This means that NBP’s stock grew somewhat faster than INDP’s over the last 12 months.

NBP's Profit vs Risk Rating (100) in the null industry is in the same range as INDP (100). This means that NBP’s stock grew similarly to INDP’s over the last 12 months.

NBP's SMR Rating (97) in the null industry is in the same range as INDP (100). This means that NBP’s stock grew similarly to INDP’s over the last 12 months.

INDP's Price Growth Rating (61) in the null industry is in the same range as NBP (82). This means that INDP’s stock grew similarly to NBP’s over the last 12 months.

NBP's P/E Growth Rating (19) in the null industry is somewhat better than the same rating for INDP (75). This means that NBP’s stock grew somewhat faster than INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDPNBP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (INDP: $3.16 vs. NBP: $1.37)
Brand notoriety: INDP and NBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INDP: 38% vs. NBP: 115%
Market capitalization -- INDP: $398.39M vs. NBP: $153.81M
INDP [@Biotechnology] is valued at $398.39M. NBP’s [@Biotechnology] market capitalization is $153.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDP’s FA Score shows that 0 FA rating(s) are green while NBP’s FA Score has 1 green FA rating(s).

  • INDP’s FA Score: 0 green, 5 red.
  • NBP’s FA Score: 1 green, 4 red.
According to our system of comparison, NBP is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDP’s TA Score shows that 4 TA indicator(s) are bullish while NBP’s TA Score has 6 bullish TA indicator(s).

  • INDP’s TA Score: 4 bullish, 4 bearish.
  • NBP’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NBP is a better buy in the short-term than INDP.

Price Growth

INDP (@Biotechnology) experienced а +42.99% price change this week, while NBP (@Biotechnology) price change was +7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

INDP is expected to report earnings on Nov 11, 2026.

NBP is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
INDP
Daily Signal:
Gain/Loss:
NBP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with VERU. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+6.76%
VERU - INDP
47%
Loosely correlated
-3.36%
ALT - INDP
45%
Loosely correlated
-3.04%
NBP - INDP
38%
Loosely correlated
-3.86%
VKTX - INDP
30%
Poorly correlated
-1.24%
ORMP - INDP
29%
Poorly correlated
-0.24%
More

NBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBP has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NBP jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBP
1D Price
Change %
NBP100%
-3.86%
VCYT - NBP
43%
Loosely correlated
+3.19%
INDP - NBP
39%
Loosely correlated
+6.76%
IMNM - NBP
37%
Loosely correlated
+0.45%
CABA - NBP
37%
Loosely correlated
-4.35%
VSTM - NBP
36%
Loosely correlated
-1.39%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSTR3.200.20
+6.67%
NorthStar Earth & Space Enterprises Inc
DSGX92.392.16
+2.39%
Descartes Systems Group
NBHC38.03N/A
N/A
NATIONAL BANK HOLDINGS Corp
DSAC10.12N/A
N/A
Daedalus Special Acquisition Corp
XPL0.50-0.02
-2.94%
Solitario Resources Corp